13. Safety investigation of “Thong Ta Yeu Phuong” capsules: Assessment of acute and subchronic toxicity in the experiment
Nội dung chính của bài viết
Tóm tắt
“Thong ta yeu phuong” capsules contained natural materials including Atractylodes macrocephala Koidz., Paeonia lactiflora Pall., Pericarpium Citri Reticulatae, and Ligusticum brachylobum Franch. “Thong ta yeu phuong” capsules were intended to support treating gastrointestinal disorders. So far, the safety of this product, however, has not yet beenreported. Thus, this study aimed to investigate the acute and subchronic toxicities of “Thong ta yeu phuong” capsules through oral administration in experimental animals. The acute toxicity was determined using the Litchfield Wilcoxon method in mice. Following WHO's recommendation, the subchronic toxicity was assessed in rabbits with oral doses of 0.28 g/kg/day and 0.84 g/kg/day for 4 consecutive weeks. In the acute toxicity test, mice given an administration of “Thong ta yeu phuong” capsules at the highest dose (60.0 g/kg) showed no abnormal sign or death. In terms of the subchronic toxicity test, after oral administration of “Thong ta yeu phuong” capsules, hematological parameters and liver function were unchanged as compared with the control group, and no gross lesions in organs were observed in all experimental animals. However, “Thong ta yeu phuong” capsules caused a significant increase in the creatinine level after 4 weeks of treatment. Hence, in clinical practice, “Thong ta yeu phuong” capsules should be used with caution if taken for a long time because of their impact on the function of the kidney.
Chi tiết bài viết
Từ khóa
“Thong ta yeu phuong” capsules, acute toxicity, subchronic toxicity, experimental animals
Tài liệu tham khảo
2. World Health Organization, Global report on traditional and complementary medicine; 2019.
3. Anywar G, Kakudidi E, Byamukama R, et al. A Review of the Toxicity and Phytochemistry of Medicinal Plant Species Used by Herbalists in Treating People Living With HIV/AIDS in Uganda. Front Pharmacol. 2021 Apr 15; 12: 615147.
4. Jitareanu A., Trifan A., Vieriu M., et al. Current Trends in Toxicity Assessment of Herbal Medicines: A Narrative Review. Processes. 2022; 11(1): 83.
5. Song HP, Li RL, Zhou C, et al. Atractylodes macrocephala Koidz stimulates intestinal epithelial cell migration through a polyamine dependent mechanism. J Ethnopharmacol. 2015 Jan 15; 159: 23-35.
6. Huang W, Percie du Sert N, Vollert J, et al. General Principles of Preclinical Study Design. Handb Exp Pharmacol. 2020; 257: 55-69.
7. World Health Organization, Guidelines for Assessing Quality of Herbal Medicines With Reference to Contaminants and Residues, Geneva; 2007.
8. Litchfield J T& Wilcoxon F A. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949; 96: 99-113.
9. Choi HK, Roh HS, Jeong JY, et al. Acute Oral Toxicity of Atractylodes macrocepala KOIDZ. Korean Journal of Plant Resources. 2014; 27(1): 11-21.
10. World Health Organization, Working group on the safety and efficacy of herbal medicine. Report of regional office for the western pacific of the World Health Organization; 2000.
11. Lee M, Seo C, Cha S, et al. Safety assessment of So-cheong-ryong-tang: subchronic toxicity study in Crl: CD Sprague Dawley rabbits. Mol Med Rep. 2014; 9: 2273–2282.
12. Olson H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regulatory Toxicology and Pharmacology. 2000; 32(1): 56-67.
13. Paul Owusu Donkor, Ying Chen, Liqin Ding, et al. Locally and traditionally used Ligusticum species - A review of their phytochemistry, pharmacology and pharmacokinetics. Journal of Ethnopharmacology. 2016; 194: 530-548.